GO:0015729 oxaloacetate transport: Mitochondrial Metabolic Shuttle, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015729 oxaloacetate transport describes the biological process by which the four-carbon dicarboxylic acid oxaloacetate is moved across cellular membranes, most notably the inner mitochondrial membrane.
• Oxaloacetate cannot freely diffuse across lipid bilayers; its transport is mediated by specific carrier proteins or by enzymatic conversion to transportable intermediates such as malate and aspartate.
• In plant mitochondria, oxaloacetate transport is essential for gluconeogenesis, the tricarboxylic acid cycle, and the malate-aspartate shuttle.
• The oxaloacetate decarboxylase sodium pump provides a structurally characterized example of a membrane protein that binds and translocates oxaloacetate, coupling its decarboxylation to sodium ion transport.
• Dysregulation of mitochondrial oxaloacetate handling is linked to liver injury, ferroptosis, and metabolic stress through autophagy-related pathways.
• CRISPR knockout, point-mutation, and overexpression models are powerful tools to dissect the causal role of candidate oxaloacetate transport genes in metabolism and disease.
Description
Oxaloacetate transport (GO:0015729) is a biological process that enables the movement of the four-carbon dicarboxylic acid oxaloacetate across cellular membranes, particularly the inner mitochondrial membrane. Because oxaloacetate is a charged, hydrophilic metabolite, it cannot passively diffuse through lipid bilayers; instead, its transport requires specific carrier proteins or enzymatic conversion into shuttle intermediates such as malate and aspartate. This process is central to gluconeogenesis, the tricarboxylic acid cycle, and the malate-aspartate shuttle, which together maintain metabolic homeostasis in plants, animals, and microorganisms. In plant mitochondria, early biochemical studies characterized oxaloacetate transport as a carrier-mediated process that is distinct from the transport of other dicarboxylates and is essential for gluconeogenesis from organic acids. In animal systems, the oxaloacetate decarboxylase sodium pump from Klebsiella pneumoniae has provided structural insights into how a membrane protein can bind oxaloacetate, decarboxylate it, and couple this reaction to sodium ion translocation. These findings established oxaloacetate transport as a paradigm for understanding metabolite transport and energy coupling. For researchers, GO:0015729 matters because oxaloacetate sits at the intersection of carbohydrate metabolism, amino acid metabolism, and mitochondrial energy production. Defects in oxaloacetate handling have been linked to liver injury, ferroptosis, and autophagic stress in model systems. Understanding the genes and mechanisms that control oxaloacetate transport is therefore critical for metabolic engineering, drug discovery, and the development of CRISPR-based disease models.
oxaloacetate transport At A Glance
| GO ID | GO:0015729 |
|---|---|
| GO term | oxaloacetate transport |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Carrier-mediated movement of oxaloacetate across membranes, supporting gluconeogenesis, the TCA cycle, and the malate-aspartate shuttle |
| Substrate | Oxaloacetate (four-carbon dicarboxylic acid) |
| Cellular location | Inner mitochondrial membrane and related organelle membranes |
| Related process | Malate-aspartate shuttle, gluconeogenesis, mitochondrial metabolism |
| Structural example | Oxaloacetate decarboxylase sodium pump (Klebsiella pneumoniae) |
What Is GO:0015729?
GO:0015729 oxaloacetate transport is defined as the directed movement of oxaloacetate into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. In practice, this process encompasses the carrier-mediated translocation of oxaloacetate across the inner mitochondrial membrane and related membranes, as well as the enzymatic shuttling of oxaloacetate equivalents via malate and aspartate. The term is a biological process in the Gene Ontology and is distinct from the molecular function of an individual oxaloacetate transporter or the cellular component of the mitochondrial membrane.
Why Is oxaloacetate transport Important in Cell Biology?
Oxaloacetate transport is important because oxaloacetate is a central metabolic intermediate that cannot cross membranes on its own; its transport therefore controls flux through gluconeogenesis, the TCA cycle, and the malate-aspartate shuttle. In plants, oxaloacetate transport into mitochondria is required for gluconeogenesis from organic acids and for the oxidation of organic acids in the TCA cycle. In bacteria, the oxaloacetate decarboxylase sodium pump couples oxaloacetate decarboxylation to sodium transport, generating an electrochemical gradient. In animals, perturbations in mitochondrial oxaloacetate handling are associated with liver injury, ferroptosis, and autophagic dysfunction, making this process a target for metabolic and disease research.
• Supports gluconeogenesis by allowing oxaloacetate to enter or leave mitochondria as needed for glucose synthesis.
• Feeds the TCA cycle by maintaining oxaloacetate availability for citrate synthase.
• Enables the malate-aspartate shuttle, which transfers reducing equivalents across the inner mitochondrial membrane.
• Provides a model for understanding sodium-coupled decarboxylation and membrane transport energetics.
• Links to liver injury and ferroptosis through autophagy-related pathways.
• Is essential for plant mitochondrial metabolism and organic acid oxidation.
• Represents a target for metabolic engineering and herbicide development in plants.
• Offers a paradigm for studying carrier proteins and transport kinetics in mitochondria.
• Can be studied with CRISPR knockout and overexpression models to test causal roles in disease.
• Connects to broader mitochondrial quality control and mitophagy pathways.
What Happens During oxaloacetate transport?
Substrate recognition and binding at the membrane
In simple terms: The transporter first grabs oxaloacetate on one side of the membrane.
Oxaloacetate transport begins when a membrane-associated carrier or enzyme recognizes and binds oxaloacetate. In plant mitochondria, early studies demonstrated that oxaloacetate transport is a carrier-mediated process with specific kinetic properties distinct from those of other dicarboxylates. The oxaloacetate decarboxylase sodium pump provides a structural example of how a membrane protein binds oxaloacetate and positions it for catalysis and transport. This binding step is saturable and can be inhibited by structural analogs, indicating the involvement of specific protein binding sites.
Translocation across the inner mitochondrial membrane
In simple terms: The bound oxaloacetate is moved across the membrane.
After binding, oxaloacetate or its equivalent is translocated across the inner mitochondrial membrane. In plant mitochondria, oxaloacetate transport is required for gluconeogenesis and for the oxidation of organic acids, and it is thought to involve specific carrier proteins rather than free diffusion. The malate-aspartate shuttle provides an indirect route: oxaloacetate is converted to malate or aspartate, which are transported, and then reconverted to oxaloacetate on the other side. This shuttle mechanism allows reducing equivalents and carbon skeletons to cross the membrane without direct oxaloacetate translocation.
Coupling to decarboxylation and ion transport
In simple terms: In some bacteria, moving oxaloacetate is linked to pumping sodium ions.
The oxaloacetate decarboxylase sodium pump couples the decarboxylation of oxaloacetate to the translocation of sodium ions across the membrane, generating an electrochemical sodium gradient. Structural studies have revealed the architecture of this pump and provided insights into how sodium transport is driven by the decarboxylation reaction. This mechanism illustrates how oxaloacetate transport can be energetically coupled to ion movement, a principle that may apply to other oxaloacetate-handling systems.
Release and metabolic integration
In simple terms: Once across, oxaloacetate enters metabolic pathways.
After translocation, oxaloacetate is released into the mitochondrial matrix or cytosol, where it participates in the TCA cycle, gluconeogenesis, and amino acid metabolism. In plants, the transported oxaloacetate can be used for citrate synthesis or converted to phosphoenolpyruvate for gluconeogenesis. In animals, oxaloacetate availability influences mitochondrial respiration and the malate-aspartate shuttle. Dysregulation of these steps has been linked to liver injury and ferroptosis in model systems.
Regulation by cellular energy status
In simple terms: The cell adjusts oxaloacetate transport based on its energy needs.
Oxaloacetate transport is regulated by cellular energy status and metabolic demand. AMPK signaling, which senses energy stress, protects against alcohol-induced liver injury through mitophagy regulation. Similarly, mitochondrial homeostasis pathways involving OPTN-dependent mitophagy influence drug-induced liver injury. These findings suggest that oxaloacetate transport and related mitochondrial functions are integrated with autophagy and energy-sensing networks.
Key Genes Involved in GO:0015729 oxaloacetate transport
The following genes and proteins have been implicated in oxaloacetate transport or in related mitochondrial metabolic and autophagic pathways that influence oxaloacetate handling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| OAD | Oxaloacetate decarboxylase sodium pump subunit; binds and decarboxylates oxaloacetate | Structural and mechanistic studies of sodium-coupled transport |
| UQCRC2 | Mitochondrial complex III subunit; supports mitophagy and mitochondrial function | AMPK-mediated protection against alcohol-induced liver injury |
| OPTN | Optineurin; adaptor for selective autophagy and mitophagy | Preserves mitochondrial homeostasis in drug-induced liver injury |
| UBQLN1 | Ubiquilin 1; regulates proteasomal degradation of autophagic SNARE proteins | Modulates septic liver injury via CD36 |
| CD36 | Fatty acid translocase; modulates UBQLN1-mediated degradation | Hepatocyte CD36 in septic liver injury |
| AMPK | Energy sensor kinase; regulates mitophagy and metabolism | Protects against alcohol-induced liver injury |
| m6A-related factors | RNA methylation machinery; regulates ferritinophagy | SFTSV-induced liver ferroptosis |
| Ferritin | Iron storage protein; targeted by ferritinophagy | Ferroptosis in liver injury |
| Mitochondrial carriers (plant) | Transport oxaloacetate across inner mitochondrial membrane | Plant gluconeogenesis and TCA cycle |
| Malate dehydrogenase | Interconverts malate and oxaloacetate | Malate-aspartate shuttle |
| Aspartate aminotransferase | Interconverts aspartate and oxaloacetate | Malate-aspartate shuttle |
| Citrate synthase | Condenses oxaloacetate and acetyl-CoA to citrate | TCA cycle flux |
| Phosphoenolpyruvate carboxykinase | Converts oxaloacetate to phosphoenolpyruvate | Gluconeogenesis |
| Pyruvate carboxylase | Generates oxaloacetate from pyruvate | Gluconeogenesis and anaplerosis |
| SNARE proteins | Mediate autophagosome-lysosome fusion | Regulated by UBQLN1 in liver injury |
| Sodium ion transporters | Couple ion gradients to transport | Oxaloacetate decarboxylase sodium pump |
How Is oxaloacetate transport Regulated?
Oxaloacetate transport is regulated at multiple levels. In plant mitochondria, transport activity is influenced by substrate availability and by the metabolic demand for gluconeogenesis and TCA cycle intermediates. In bacteria, the oxaloacetate decarboxylase sodium pump is regulated by sodium gradients and by the availability of oxaloacetate. In animal cells, mitochondrial homeostasis and oxaloacetate handling are integrated with autophagy and mitophagy pathways; AMPK signaling protects against alcohol-induced liver injury through UQCRC2-mediated mitophagy, and OPTN-dependent mitophagy preserves mitochondrial homeostasis in drug-induced liver injury. Additionally, CD36 modulates UBQLN1-mediated degradation of autophagic SNARE proteins, linking lipid metabolism to autophagic regulation in septic liver injury. These pathways collectively influence mitochondrial function and oxaloacetate-related metabolism.
oxaloacetate transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UQCRC2 | Alcohol-induced liver injury | Knockout or overexpression in hepatocytes |
| OPTN | Drug-induced liver injury | Knockout mouse or cell line |
| CD36 | Septic liver injury | Hepatocyte-specific knockout |
| m6A-related factors | SFTSV-induced liver ferroptosis | Knockdown or knockout in liver cells |
| Plant mitochondrial carriers | Gluconeogenesis defects | Arabidopsis knockout mutants |
Liver injury and metabolic stress
Oxaloacetate transport and related mitochondrial functions are implicated in liver injury. AMPK protects against alcohol-induced liver injury through UQCRC2 to up-regulate mitophagy. Preserving mitochondrial homeostasis via OPTN-dependent mitophagy protects against drug-induced liver injury. Hepatocyte CD36 modulates UBQLN1-mediated proteasomal degradation of autophagic SNARE proteins, contributing to septic liver injury. These studies highlight the importance of mitochondrial metabolic pathways, including oxaloacetate handling, in liver disease.
Ferroptosis and iron metabolism
SFTSV induces liver ferroptosis through m6A-related ferritinophagy. Ferroptosis is an iron-dependent form of cell death that intersects with mitochondrial metabolism. Although direct links between oxaloacetate transport and ferroptosis remain to be fully established, the shared involvement of mitochondrial dysfunction and autophagy pathways suggests a potential connection.
Plant metabolism and agriculture
In plants, oxaloacetate transport into mitochondria is essential for gluconeogenesis and organic acid oxidation. Disruption of this process could affect seed germination, carbon partitioning, and stress responses. Understanding plant oxaloacetate transport may inform crop improvement and herbicide development.
From oxaloacetate transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate oxaloacetate transporter impair gluconeogenesis? | CRISPR knockout in hepatocytes or plant cells |
| Does a point mutation in the oxaloacetate binding site alter transport kinetics? | CRISPR point-mutation knock-in |
| Can overexpression of a transporter enhance metabolic flux? | CRISPR overexpression cell line |
| How does tagging a transporter affect its localization? | Knock-in with fluorescent or epitope tag |
| Does a transporter interact with autophagy proteins? | Co-immunoprecipitation in knockout background |
| What is the role of oxaloacetate transport in liver injury? | Liver-specific knockout mouse |
How to Study the oxaloacetate transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isolated mitochondria transport assay | Oxaloacetate uptake kinetics | Plant and animal mitochondrial studies |
| Cryo-EM | Protein structure and conformational changes | Oxaloacetate decarboxylase sodium pump |
| CRISPR knockout screen | Gene requirement for transport | Mammalian cell lines |
| Isotope tracing | Metabolic flux through oxaloacetate | Gluconeogenesis and TCA cycle |
| Co-immunoprecipitation | Protein-protein interactions | Autophagy-related complexes |
| Live-cell imaging | Subcellular localization | Tagged transporters |
| RNA-seq | Transcriptional changes | Knockout vs wild-type |
| Proteomics | Protein abundance and modifications | Mitochondrial fractions |
Biochemical transport assays
Biochemical assays using isolated mitochondria or membrane vesicles can measure oxaloacetate transport kinetics, substrate specificity, and inhibitor sensitivity. These methods were instrumental in characterizing plant mitochondrial oxaloacetate transport and distinguishing it from other dicarboxylate carriers.
Structural biology
Structural studies, such as those on the oxaloacetate decarboxylase sodium pump, reveal the molecular architecture of oxaloacetate binding and translocation. Cryo-EM and X-ray crystallography can provide insights into conformational changes during transport.
CRISPR-based genetic screens
CRISPR knockout and activation screens can identify genes required for oxaloacetate transport and related metabolic pathways. These screens are particularly useful for uncovering novel transporters and regulators in mammalian cells.
Metabolic flux analysis
Isotope tracing and metabolomics can quantify flux through oxaloacetate-dependent pathways such as gluconeogenesis and the TCA cycle. Combining these methods with CRISPR models allows causal testing of candidate genes.
How CRISPR Can Be Used to Study GO:0015729 oxaloacetate transport
Knockout
CRISPR knockout of candidate oxaloacetate transport genes can reveal their essentiality for gluconeogenesis, TCA cycle function, and mitochondrial metabolism. For example, knocking out UQCRC2 or OPTN in liver cells has been used to study mitophagy and liver injury. Knockout models are also valuable in plants to assess the role of mitochondrial carriers in gluconeogenesis.
Point Mutation
CRISPR point-mutation knock-in can introduce specific amino acid substitutions in transporter active sites to dissect binding and translocation mechanisms. This approach is particularly useful for testing residues identified in structural studies of the oxaloacetate decarboxylase sodium pump.
Knock-in
Knock-in of fluorescent or epitope tags allows visualization and purification of oxaloacetate transporters. Tagged knock-in models can be used to track subcellular localization and dynamic changes during metabolic shifts.
Overexpression
CRISPR-mediated overexpression of oxaloacetate transporters or related metabolic genes can enhance flux through gluconeogenesis or the TCA cycle. Overexpression models are useful for testing whether increased transport capacity alters cellular metabolism or disease phenotypes.
How EDITGENE Supports oxaloacetate transport Research
Researchers studying oxaloacetate transport-related genes often need to determine whether a candidate gene is causally involved in metabolite movement, mitochondrial function, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for oxaloacetate transport research.
Frequently Asked Questions About oxaloacetate transport
What is oxaloacetate transport?
Oxaloacetate transport (GO:0015729) is the biological process of moving oxaloacetate across cellular membranes, typically the inner mitochondrial membrane, via specific carrier proteins or shuttle mechanisms.
What genes are involved in oxaloacetate transport?
Genes encoding mitochondrial carriers, malate dehydrogenase, aspartate aminotransferase, and the oxaloacetate decarboxylase sodium pump are involved in oxaloacetate transport and related shuttles.
Why is oxaloacetate transport important for metabolism?
It supports gluconeogenesis, the TCA cycle, and the malate-aspartate shuttle, which are essential for energy production and glucose homeostasis.
How is oxaloacetate transported across the inner mitochondrial membrane?
Oxaloacetate is transported by specific carrier proteins or indirectly via the malate-aspartate shuttle, where it is converted to malate or aspartate for translocation.
What diseases are linked to oxaloacetate transport?
Dysregulation of mitochondrial oxaloacetate handling has been associated with liver injury, ferroptosis, and autophagic stress in model systems.
Can CRISPR be used to study oxaloacetate transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the function of genes involved in oxaloacetate transport.
What is the oxaloacetate decarboxylase sodium pump?
It is a bacterial membrane protein that couples oxaloacetate decarboxylation to sodium ion transport, providing structural insights into oxaloacetate handling.
How is oxaloacetate transport studied in plants?
Plant mitochondrial oxaloacetate transport is studied using isolated mitochondria, transport assays, and mutant analysis to understand its role in gluconeogenesis and the TCA cycle.
What is the malate-aspartate shuttle?
The malate-aspartate shuttle is a mechanism that transfers reducing equivalents across the inner mitochondrial membrane using malate and aspartate, indirectly involving oxaloacetate.
What research methods are used for oxaloacetate transport?
Methods include biochemical transport assays, structural biology, CRISPR screens, metabolic flux analysis, and proteomics.
Conclusion
Oxaloacetate transport (GO:0015729) is a fundamental biological process that enables the movement of a key metabolic intermediate across cellular membranes, supporting gluconeogenesis, the TCA cycle, and the malate-aspartate shuttle. Structural and biochemical studies have revealed diverse mechanisms, from carrier-mediated transport in plant mitochondria to the sodium-coupled oxaloacetate decarboxylase pump in bacteria. Dysregulation of oxaloacetate handling is linked to liver injury, ferroptosis, and autophagic stress, highlighting its clinical relevance. CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, offer powerful tools to dissect the causal roles of genes involved in oxaloacetate transport. EDITGENE provides comprehensive services to support such research, from custom cell line generation to CRISPR library screening and bioinformatics analysis. By combining precise genome editing with metabolic and imaging assays, researchers can advance our understanding of oxaloacetate transport in health and disease.
References
- 1. Lu X et al.. 2021. AMPK protects against alcohol-induced liver injury through UQCRC2 to up-regulate mitophagy.. Autophagy 17(11):3622-3643 PMID: 33719895
- 2. Liu B et al.. 2025. SFTSV induces liver ferroptosis through m6A-related ferritinophagy.. Autophagy 21(11):2353-2366 PMID: 40340535
- 3. Wang J et al.. 2024. Preserving mitochondrial homeostasis protects against drug-induced liver injury via inducing OPTN (optineurin)-dependent Mitophagy.. Autophagy 20(12):2677-2696 PMID: 39099169
- 4. Xu X et al.. 2020. Structural insights into sodium transport by the oxaloacetate decarboxylase sodium pump.. Elife 9 PMID: 32459174
- 5. Li Y et al.. 2023. Hepatocyte CD36 modulates UBQLN1-mediated proteasomal degradation of autophagic SNARE proteins contributing to septic liver injury.. Autophagy 19(9):2504-2519 PMID: 37014234
- 6. Hanning I I et al.. 1999. Oxaloacetate transport into plant mitochondria.. Plant Physiol 119(3):1025-32 PMID: 10069840
- 7. Darvey IG. 2000. Does the transport of oxaloacetate across the inner mitochondrial membrane during gluconeogenesis require carrier proteins other than those used in the malate-aspartate shuttle?. Biochem Educ 28(2):80-82 PMID: 10722937
- 8. Oliver DJ et al.. 1984. Characterization of the transport of oxaloacetate by pea leaf mitochondria.. Plant Physiol 76(2):409-13 PMID: 16663855
